Navigation Links
PFCD Experts Cite Health Information Technology as Key Investment for Economic Stimulus
Date:1/14/2009

rovides easy access to comprehensive patient records electronically, thus making it easier to see a patient's medical history;
  • Helps providers track patient care in order to reduce duplication of services, address patient issues, and coordinate care with care managers;
  • Offers providers access to reference materials during a patient visit;
  • Provides clinicians real-time guidance on standards of care; and
  • Sends reminders and prompts to patients about visits, tests, and recommendations and prescriptions.

    • Unfortunately, the health system is not yet routinely using HIT to improve Americans' care quality. Only one in five (20 percent) of U.S. patients has computerized health records.

    The PFCD Policy Platform can be accessed at: http://www.fightchronicdisease.org/issues/policy.cfm

    About the Partnership to Fight Chronic Disease:

    The Partnership to Fight Chronic Disease (PFCD) is a national coalition of patients, providers, community organizations, business and labor groups, and health policy experts committed to raising awareness of the number one cause of death, disability, and rising health care costs in the U.S.: chronic disease. For more information about the PFCD and its partner organizations, please visit: http://www.fightchronicdisease.org.


    '/>"/>
    SOURCE Partnership to Fight Chronic Disease
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2

    Related medicine news :

    1. Medical Experts Call for Obama Administration, Congress to Boost Funding for Prostate Cancer Imaging Research
    2. New Experts Help New England Peptide Combat Global Acetonitrile Shortage; Company Integrating Cost-Effective Chemical Solvent Alternatives
    3. Collexis BiomedExperts Hits 80,000 Registered Users Within the First Year!
    4. Experts Say Blood Sugar Guidelines Remain Effective
    5. Plastic Surgery Experts Available to Comment on Face Transplant Surgery
    6. Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures
    7. MaxCyte Presents a Panel Discussion With Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery - LIVE Q&A to Follow
    8. Holland & Knight Welcomes MARC Associates - Experts in Health Care and Intergovernmental Policy - to the Firms Public Policy & Regulation Practice
    9. Experts Highlight New Tool as a Timely Addition to Asthma Treatment
    10. Instrumentation Laboratory Announces ILeader Panel of Experts as Part of 50th Anniversary Program
    11. Analog Devices Healthcare Team Participates in MIT Forum on Medical Device Industry : ADI's healthcare technology experts Patrick O'Doherty and Tom O'Dwyer offer insights on trends impacting next-generation medical electronic systems.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Other Medicine Technology:Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 2Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 3Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 4Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 5Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 2Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 3Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 4Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 5Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 6Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 7Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 8Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 9